Such novel findings indicated that bladder cancer cells enhanced CXCL9 in TADCs, which significantly up-regulated PD-L1 expression in cancer cells by activating the CXCR3-related STAT3/Akt signaling. The gene discussed is CXCL9; the disease is urinary bladder cancer.